Full Report - Research for Development - Department for ...

Tukur (2010)
(-)/(-)
Women with
eclampsia
Labour (including induction)
Abdul (2007)
(-)/(+)
Bergsjo
(1989)
(-)/(-)
Women needing
induction
Women with
uncomplicated
pregnancies going
beyond 42 weeks
gestation
Magnesium sulphate was administered
following the Zuspan regimen (in which the
maintenance doses are given
intravenously).
Induction of labour by misoprostol
(intravaginal 50 microg. 6-hourly to a
maximum of four doses) or oxytocin
(maximum of 48 iu/min).
Induction of labour by stripping of
membranes and intravenous. oxytocin
infusion, with artificial rupture of
membranes when the cervical opening was
3 cm or more in diameter. The control
group was followed with clinical,
biochemical and electronic tests,
intervention being applied according to
needs.
Maternal
mortality
Perinatal
mortality
Maternal
mortality
Stillbirth
Neonatal
mortality
Appendix 4.1
This study is in support of the findings
that magnesium sulphate is superior to
diazepam in the reduction of maternal
morbidity and mortality. However, the
benefit to the infant was not
statistically significant.
No case of maternal mortality was
recorded. The efficacy of misoprostol in
the induction of third trimester labour is
comparable to oxytocin.
Maternal complications and perinatal
morbidity rates were equally distributed
between the groups. There was one
perinatal death in the induction group
and two deaths among the controls. No
advantage of induction shown.
What are the effects of different models of delivery for improving maternal and infant health outcomes for poor people in urban areas in low income
and lower middle income countries?
198